Literature DB >> 16847721

Methamphetamine-induced behavioral sensitization in mice: alterations in mu-opioid receptor.

Chi-Tso Chiu1, Tangeng Ma, Ing K Ho.   

Abstract

We had previously demonstrated that opioid receptors contribute to the induction and expression of behavioral sensitization induced by repeated daily injection with 2.5 mg/kg of methamphetamine for 7 days. Using the same regimen, the present study investigated the alterations in mu-opioid receptor during the induction (on days 2, 5, and 8) and expression (on days 11 and 21) periods of behavioral sensitization. Radioligand binding revealed that the maximal binding of mu-opioid receptor was not changed on days 2 and 5, but down-regulated on day 8. After cessation of drug treatment, the maximal binding of mu-opioid receptor gradually and time-dependently returned to normal level on day 11 and up-regulated on day 21. In contrast, no changes in delta- and kappa-opioid receptors were detectable on any given day examined. The potency of DAMGO for [(35)S]-GTPgammaS coupling was enhanced on days 2, 5, 11, and 21. Moreover, 1 muM of naltrexone or beta-chlornaltrexamine significantly suppressed the basal [(35)S]-GTPgammaS coupling on days 2, 11, and 21. These findings indicate enhanced responsiveness and elevated constitutive activity of mu-opioid receptor. In summary, our data clearly demonstrate that alterations in mu-opioid receptor are involved in and may contribute to the sensitization to locomotor stimulating effect of methamphetamine.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16847721      PMCID: PMC2925105          DOI: 10.1007/s11373-006-9102-x

Source DB:  PubMed          Journal:  J Biomed Sci        ISSN: 1021-7770            Impact factor:   8.410


  65 in total

1.  Mu-opioid receptor knockout mice show diminished food-anticipatory activity.

Authors:  Martien J H Kas; Ruud van den Bos; Annemarie M Baars; Marianne Lubbers; Heidi M B Lesscher; Jacquelien J G Hillebrand; Alwin G Schuller; John E Pintar; Berry M Spruijt
Journal:  Eur J Neurosci       Date:  2004-09       Impact factor: 3.386

Review 2.  Anatomy of CNS opioid receptors.

Authors:  A Mansour; H Khachaturian; M E Lewis; H Akil; S J Watson
Journal:  Trends Neurosci       Date:  1988-07       Impact factor: 13.837

Review 3.  A psychomotor stimulant theory of addiction.

Authors:  R A Wise; M A Bozarth
Journal:  Psychol Rev       Date:  1987-10       Impact factor: 8.934

4.  Sensitization occurs to the locomotor effects of morphine and the specific mu opioid receptor agonist, DAGO, administered repeatedly to the ventral tegmental area but not to the nucleus accumbens.

Authors:  P Vezina; P W Kalivas; J Stewart
Journal:  Brain Res       Date:  1987-08-04       Impact factor: 3.252

5.  Chronic amphetamine alters D-2 but not D-1 agonist-induced behavioral responses in rats.

Authors:  A D Levy; J J Kim; G D Ellison
Journal:  Life Sci       Date:  1988       Impact factor: 5.037

Review 6.  Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis.

Authors:  T E Robinson; J B Becker
Journal:  Brain Res       Date:  1986-06       Impact factor: 3.252

7.  Amphetamine administered to the ventral tegmental area but not to the nucleus accumbens sensitizes rats to systemic morphine: lack of conditioned effects.

Authors:  P Vezina; J Stewart
Journal:  Brain Res       Date:  1990-05-14       Impact factor: 3.252

8.  Long-term behavioral and neuronal cross-sensitization to amphetamine induced by repeated brief social defeat stress: Fos in the ventral tegmental area and amygdala.

Authors:  E M Nikulina; H E Covington; L Ganschow; R P Hammer; K A Miczek
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

9.  Anatomical analysis of the involvement of mesolimbocortical dopamine in the locomotor stimulant actions of d-amphetamine and apomorphine.

Authors:  P B Clarke; A Jakubovic; H C Fibiger
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

10.  Enhanced spontaneous activity of the mu opioid receptor by cysteine mutations: characterization of a tool for inverse agonist screening.

Authors:  Karl Brillet; Brigitte L Kieffer; Dominique Massotte
Journal:  BMC Pharmacol       Date:  2003-12-01
View more
  17 in total

Review 1.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

Review 2.  Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature.

Authors:  Kelly E Courtney; Lara A Ray
Journal:  Drug Alcohol Depend       Date:  2014-08-17       Impact factor: 4.492

3.  The effects of lobeline and naltrexone on methamphetamine-induced place preference and striatal dopamine and serotonin levels in adolescent rats with a history of maternal separation.

Authors:  J J Dimatelis; V A Russell; D J Stein; W M Daniels
Journal:  Metab Brain Dis       Date:  2012-03-04       Impact factor: 3.584

4.  The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study.

Authors:  Lara A Ray; Spencer Bujarski; Kelly E Courtney; Nathasha R Moallem; Katy Lunny; Daniel Roche; Adam M Leventhal; Steve Shoptaw; Keith Heinzerling; Edythe D London; Karen Miotto
Journal:  Neuropsychopharmacology       Date:  2015-03-24       Impact factor: 7.853

5.  Methylphenidate potentiates morphine-induced antinociception, hyperthermia, and locomotor activity in young adult rats.

Authors:  Lindsay R Halladay; Sergio D Iñiguez; Faiza Furqan; Matt C Previte; Ashley M Chisum; Cynthia A Crawford
Journal:  Pharmacol Biochem Behav       Date:  2008-12-07       Impact factor: 3.533

Review 6.  Pharmacotherapy for stimulant-related disorders.

Authors:  Colin N Haile; Thomas R Kosten
Journal:  Curr Psychiatry Rep       Date:  2013-11       Impact factor: 5.285

7.  Feasibility, Acceptability, and Tolerability of Targeted Naltrexone for Nondependent Methamphetamine-Using and Binge-Drinking Men Who Have Sex with Men.

Authors:  Glenn-Milo Santos; Phillip Coffin; Deirdre Santos; Shannon Huffaker; Tim Matheson; Jason Euren; Anna DeMartini; Christopher Rowe; Judith A Hahn; David Vlahov; Eric Vittinghoff; Steven L Batki
Journal:  J Acquir Immune Defic Syndr       Date:  2016-05-01       Impact factor: 3.731

8.  Differential modulation of methamphetamine-mediated behavioral sensitization by overexpression of Mu opioid receptors in nucleus accumbens and ventral tegmental area.

Authors:  Chi-Chung Kuo; Hui Shen; Brandon K Harvey; Seong-Jin Yu; Theresa Kopajtic; Josh J Hinkle; Stephanos Kyrkanides; Jonathan L Katz; Yun Wang
Journal:  Psychopharmacology (Berl)       Date:  2015-11-10       Impact factor: 4.530

9.  MOP Reduction During Long-Term Methamphetamine Withdrawal was Restored by Chronic Post-Treatment with Fluoxetine.

Authors:  H Yamamoto; Y Takamatsu; K Imai; E Kamegaya; Y Hagino; M Watanabe; T Yamamoto; I Sora; H Koga; K Ikeda
Journal:  Curr Neuropharmacol       Date:  2011-03       Impact factor: 7.363

10.  Involvement of µ-Opioid Receptor in Methamphetamine-Induced Behavioral Sensitization.

Authors:  Lu-Tai Tien; Ing-Kang Ho
Journal:  Curr Neuropharmacol       Date:  2011-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.